We focus on the in-licensing, registration and commercialization of niche pharmaceutical products, characterised by inherent barriers to market entry. Specialising in value-added therapeutics, we target categories typically dominated by costly and/or inferior medicines, and in need of new efficiencies. Our product portfolio features a diverse range of branded, generic, and biosimilar medicines that are sold across our global distribution channels, supporting the health of thousands of patients annually.
